Wegovy, Oral Wegovy, Zepbound, and Foundayo are all FDA-approved specifically for chronic weight management, and Klinic prescribes all of them
This recommendation was developed following 6 cases of non-fatal aspiration in fasted patients taking GLP-1 RAs, and is aimed at reducing the risk of the much-feared pulmonary aspiration seen in unfasted patients with an unprotected airway
[147] [149] [168] In particular, aerobic exercise decreases psychostimulant self-administration, reduces the reinstatement (i.e., relapse) of drug-seeking, and induces increased dopamine receptor D 2 (DRD2) density in the striatum
Dorfman SG, Copperman MT, Nelson RL, Depuy H, Peake RL, Young RL
Other medications within these classes have demonstrated weight loss efficacy but are not FDA approved for weight loss (eg, medications approved for diabetes that can induce weight loss) and therefore are not included in the table